SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 125 filers reported holding SERES THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $114 | -42.7% | 48,095 | +15.7% | 0.01% | -43.8% |
| Q2 2023 | $199 | +158.4% | 41,581 | +206.1% | 0.02% | +166.7% |
| Q1 2023 | $77 | -17.2% | 13,585 | -18.5% | 0.01% | -25.0% |
| Q4 2022 | $93 | -99.9% | 16,667 | +18.5% | 0.01% | 0.0% |
| Q3 2022 | $90,000 | -15.1% | 14,070 | -5.4% | 0.01% | +166.7% |
| Q1 2022 | $106,000 | +19.1% | 14,871 | +38.4% | 0.00% | 0.0% |
| Q4 2021 | $89,000 | -53.4% | 10,744 | -60.9% | 0.00% | -62.5% |
| Q3 2021 | $191,000 | – | 27,492 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $110,730,646 | 4.94% |
| Lion Point Capital, LP | 691,803 | $3,313,736 | 1.50% |
| Eversept Partners, LP | 3,076,756 | $14,737,661 | 1.23% |
| Soleus Capital Management, L.P. | 2,045,983 | $9,800,259 | 1.09% |
| Knott David M Jr | 470,000 | $2,251 | 0.90% |
| GREAT POINT PARTNERS LLC | 938,067 | $4,493,341 | 0.88% |
| Simplify Asset Management Inc. | 550,626 | $2,637,499 | 0.35% |
| Delphia (USA) Inc. | 33,913 | $162,443 | 0.26% |
| Alpha DNA Investment Management LLC | 138,536 | $663,587 | 0.22% |
| Avoro Capital Advisors LLC | 2,500,000 | $11,975,000 | 0.16% |